Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Eur Urol. 2018 Mar 5;73(6):941–948. doi: 10.1016/j.eururo.2018.02.016

Fig. 2.

Fig. 2

Risk of death from prostate cancer among men 59 yr and younger. (A) Risk of death from prostate cancer at varying levels of PSA at baseline (PSA and PSA percentile on right y axis). (B) Risk of death from prostate cancer among men providing blood at age 45–59 yr who had PSA ≥1.5 ng/ml, split by four kallikrein panel risk at 7.5% at baseline. The black line indicates the risk of prostate cancer death among all men with baseline PSA ≥1.5 ng/ml, red line indicates the risk of prostate cancer death among men with PSA ≥1.5 ng/ml and four kallikrein panel score ≥7.5% at baseline, and blue line indicates the risk of prostate cancer death among the men with PSA ≥1.5 ng/ml and four kallikrein panel score <7.5% at baseline. PSA = prostate specific antigen.